Drug Profile
Sphingosine-1 phosphate receptor-1 agonist - Bristol-Myers Squibb
Alternative Names: S1P1 agonistLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Small molecules
- Mechanism of Action Sphingosine 1 phosphate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Immunological disorders
Most Recent Events
- 28 Dec 2020 No recent reports of development identified for phase-I development in Immunological-disorders in USA
- 11 Apr 2018 Phase I development in Immunological disorders is ongoing (Bristol-Myers Squibb pipeline, April 2018)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Immunological-disorders in USA